Aims Review Committee (ARC) is a mentoring program specifically designed to enhance grants writing skills and funding for JBC investigators at all levels who are in the process of grant submission. ARC has proved to have optimized grant writing skills and funding success.
When are they held?
ACR meetings range from bimonthly to once in 2 months, depending on the number of investigators submitting their Specific Aims pages for upcoming grants.
Grants Funded
| # | Year | Grant Type | Funder | Principal Investigator | Topic |
|---|---|---|---|---|---|
| 1 | 2012 | K08 | NIH/NIAMS | Erika Noss, MD, PhD | Inflammatory arthritis |
| 2 | 2012 | K08 | NIH/NIAMS | Julia Charles, MD, PhD | Inflammatory arthritis |
| 3 | 2012 | R21 | NIH/NIAMS | Peter Nigrovic, MD | Inflammatory arthritis |
| 4 | 2012 | Scleroderma Foundation | Antonios O. Aliprantis MD, PhD | Scleroderma | |
| 5 | 2012 | R01 | NIH/NIAMS | Peter Nigrovic, MD | Neutrophil biology |
| 6 | 2013 | Pilot | RRF | Antonios O. Aliprantis MD, PhD | Inflammatory arthritis |
| 7 | 2013 | DTRG | RRF | Peter Nigrovic, MD | Inflammatory arthritis |
| 8 | 2013 | SDA | RRF | Pui Lee, MD, PhD | Monocyte biology |
| 9 | 2013 | R01 | NIH/NIA | Antonios O. Aliprantis MD, PhD | Inflammatory arthritis |
| 10 | 2014 | SDA | RRF | Lauren Henderson, MD, MMSc | Inflammatory arthritis |
| 11 | 2014 | IIRG | Novartis | Peter Nigrovic, MD | Inflammatory arthritis |
| 12 | 2014 | IIRG | Pfizer | Yvonne Lee, MD, MPH | Inflammatory arthritis |
| 13 | 2014 | R01 | NIH/NIAID | Tanya Laidlaw, MD | Aspirin-associated respiratory disease |
| 14 | 2015 | Pilot | RRF | Antonios O. Aliprantis MD, PhD | Inflammatory arthritis |
| 15 | 2015 | ANRF | Gang Li, PhD | Inflammatory arthritis | |
| 16 | 2015 | K23 | NIH/NIAMS | Jeffrey Sparks, MD, MMSc | Inflammatory arthritis |
| 17 | 2015 | Mallinckrodt | Deepak Rao, MD, PhD | Inflammatory arthritis | |
| 18 | 2015 | Mallinckrodt | Kevin Wei, MD, PhD | Inflammatory arthritis | |
| 19 | 2016 | P30 | NIH/NIAMS | Peter Nigrovic, MD | Inflammatory arthritis |
| 20 | 2016 | CDA | Lupus Research Alliance | Sara Tedeschi, MD, MPH | Osteoporosis, SLE |
| 21 | 2016 | K23 | NIH/NIAMS | Candace Feldman, MD, PhD | SLE |
| 22 | 2016 | IRA | RRF | Peter Nigrovic, MD | Inflammatory arthritis |
| 23 | 2016 | Faculty award, BWH | Julia Charles, MD, PhD | Bone biology | |
| 24 | 2017 | P30 | NIH/NIAMS | Daniel Solomon, MD, MPH | Rheumatology |
| 25 | 2017 | K08 | NIH/NIAMS | Deepak Rao, MD, PhD | Inflammatory arthritis |
| 26 | 2017 | K08 | NIH/NIAMS | Lauren Henderson, MD, MMSc | Inflammatory arthritis |
| 27 | 2018 | ANRF | A. Helena Jonsson, MD, PhD | Inflammatory arthritis | |
| 28 | 2018 | ANRF | Pierre Cunin, PhD | Inflammatory arthritis | |
| 29 | 2018 | K12 | NIH/NIAMS | Kevin Wei, MD, PhD | Inflammatory arthritis |
| 30 | 2018 | R01 | NIH/NIAMS | Peter Nigrovic, MD | Inflammatory arthritis |
| 31 | 2019 | K08 | NIH/NIAMS | Pui Lee, MD, PhD | Monocyte biology |
| 32 | 2019 | K23 | NIH/NIAMS | Sara Tedeschi, MD, MPH | Pseudogout |
| 33 | 2019 | SDA | RRF | Lindsey MacFarlane, MD | Osteoarthritis |
| 34 | 2019 | IA | RRF | Paul Hoover, MD, PhD | SLE |